Tuesday, December 6, 2022

STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...

0
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...

14 CIC Members’ Milestone Moments of 2022 — CIC

0
Founded by Brown undergrads in 2019, Providence-based Intus Care is helping health care providers deliver the best possible care to elderly patients. Intus’s...

FASHION WEEK

DON'T MISS

GADGET WORLD

STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...

0
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...

LIFESTYLE

MOBILE AND PHONES

STAY CONNECTED

21,909FansLike
3,597FollowersFollow
0SubscribersSubscribe

RECENT COMMENTS

LATEST REVIEWS

STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...

0
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...